FrancophonIA/ELRC3.0 huggingface dataset:
English: Metformin (immediate- or extended-release formulations) ≥1500 mg/day plus maximum tolerated dose, which must be at least half maximum dose, of a sulphonylurea for at least 8 weeks prior to enrolment.
Danish: glimepirid 4 mg/dag; Metformin (formulering med umiddelbar (IR) eller forlænget frigivelse (XR)) ≥1500 mg/dag plus maksimal tolereret dosis, som skal være mindst halvdelen af den maksimale dosis, af et sulfonylurinstof i mindst 8 uger inden inkludering i studiet.
English: Forxiga is used for the type of diabetes called type 2 diabetes - where your body does not make enough insulin or is not able to use the insulin it produces properly.
Danish: Forxiga anvendes til den type diabetes, som kaldes type 2-diabetes - hvor din krop ikke producerer nok insulin, eller kroppen ikke kan udnytte det insulin, som den producerer, godt nok.
English: Urine laboratory assessments Due to its mechanism of action, patients taking Forxiga will test positive for glucose in their urine.
Danish: På grund af lægemidlets virkningsmekanisme vil patienter, der tager Forxiga, få et positivt analyseresultat for glukose i urinen.
English: Forxiga 10 mg Tablets Type 2 diabetes: Medicinal product subject to medical prescription.
Danish: Forxiga 10 mg: Type 2-diabetes : Lægemidlet er receptpligtigt.
English: Table 1 Clinical stage Blood Ketone (betahydroxybutyrate)
Danish: Blodketoner (betahydroxybutyrat)
English: Forxiga is indicated in adults for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise - as monotherapy when metformin is considered inappropriate due to intolerance.
Danish: Forxiga er indiceret til voksne til behandling af utilstrækkelig kontrolleret type 2-diabetes mellitus i tillæg til diæt og motion - som monoterapi når metformin ikke anses for velegnet på grund af intolerance.
English: Forxiga should only be used in type 1 diabetes patients who are overweight or obese.
Danish: Forxiga må kun anvendes til type 1-diabetespatienter, som er overvægtige.
English: Forxiga and other diabetes medicines Forxiga is used if your type 2 diabetes cannot be controlled with diet and exercise.
Danish: Forxiga og anden diabetesmedicin Forxiga anvendes hvis din type 2-diabetes ikke kan kontrolleres med diæt og motion.
English: Forxiga is indicated in adults for the treatment of insufficiently controlled type 1 diabetes mellitus as an adjunct to insulin in patients with BMI ≥ 27 kg/m2, when insulin alone does not provide adequate glycaemic control despite optimal insulin therapy.
Danish: Forxiga er indiceret til voksne til behandling af utilstrækkeligt kontrolleret type 1-diabetes mellitus i tillæg til insulin til patienter med BMI ≥ 27 kg/m2, når insulin alene ikke giver tilstrækkelig glykæmisk kontrol på trods af optimal insulinbehandling.
English: LOCF: Last observation (prior to rescue for rescued subjects) carried forward All randomised subjects who took at least one dose of double-blind study medicinal product during the short-term double-blind period
Danish: LOCF: Last Observation Carried Forward (før behandling med rescue-medicin) Alle randomiserede forsøgspersoner, som tog mindst én dosis dobbeltblind forsøgsmedicin i den dobbeltblinde periode af korttidsstudierne
English: Forxiga should not be initiated in patients with a GFR < 60 mL/min and should be discontinued at GFR persistently below 45 mL/min.
Danish: Forxiga bør ikke initieres hos patienter med en GFR <60 ml/min og skal seponeres ved en vedvarende GFR under 45 ml/min.
English: Following an 8-week lead-in period to optimise each patient's diabetes management (glycaemic control including hyperglycaemia and hypoglycaemia, diet and exercise patterns), a total of 1,646 patients with HbA1c ≥ 7.5% and ≤ 10.5% were randomised to 5 mg dapagliflozin once daily, 10 mg dapagliflozin once daily or placebo once daily.
Danish: Efter en 8 ugers indledningsperiode for at optimere hver patients diabetesbehandling (glykæmisk kontrol inklusive hyperglykæmi og hypoglykæmi, diæt- og motionsmønstre) blev der i alt randomiseret 1.646 patienter med HbA1c ≥ 7,5 % og ≤ 10,5 % til enten 5 mg dapagliflozin en gang dagligt, 10 mg dapagliflozin en gang dagligt eller placebo en gang dagligt.
English: • Forxiga is used if your type 2 diabetes cannot be controlled with diet and exercise.
Danish: • Forxiga anvendes hvis din type 2-diabetes ikke kan kontrolleres med diæt og motion.
English: - At blood ketone readings over 1.5 to 3.0 mmol/L (or urine ketones reading ++) you may be developing diabetic ketoacidosis, seek medical advice immediately and stop taking Forxiga.
Danish: - Ved blodketonmåling mellem 1,5 og 3,0 mmol/l (eller urinketonmåling ++) kan du udvikle diabetisk ketoacidose, søg straks lægehjælp og stop med at tage Forxiga.
English: Dapagliflozin as an adjunct to adjustable insulin was studied in two 24-week randomised, doubleblind, placebo-controlled clinical studies with a 28-week extension to evaluate the efficacy and safety in adult patients with type 1 diabetes mellitus and inadequate glycaemic control (defined as HbA1c ≥ 7.5%) on insulin alone.
Danish: Dapagliflozin som et supplement til justerbart insulin blev undersøgt i to 24-ugers randomiserede, dobbeltblindede, placebokontrollerede kliniske studier med en 28-ugers forlængelse for at evaluere virkningen og sikkerheden hos voksne patienter med type 1-diabetes mellitus og utilstrækkelig glykæmisk kontrol (defineret som HbA1c ≥ 7,5 %) alene på insulin.
English: In interaction studies conducted in healthy subjects, using mainly a single-dose design, dapagliflozin did not alter the pharmacokinetics of metformin, pioglitazone, sitagliptin, glimepiride, hydrochlorothiazide, bumetanide, valsartan, digoxin (a P-gp substrate) or warfarin (S-warfarin, a CYP2C9 substrate), or the anticoagulatory effects of warfarin as measured by INR.
Danish: I interaktionsstudier med raske forsøgspersoner hovedsageligt med enkeltdosisdesign ændrede dapagliflozin ikke farmakokinetikken af metformin, pioglitazon, sitagliptin, glimepirid, hydrochlorthiazid, bumetanid, valsartan, digoxin (et P-gp-substrat) eller warfarin (S-warfarin, et CYP2C9substrat) eller de antikoagulerende virkninger af warfarin, målt ud fra INR-værdi.
English: Adjusted least squares means (LS Means) and treatment group difference(s) in the change from baseline values at Week 28 are modelled using a mixed model with repeated measures (MMRM) including treatment, region, baseline HbA1c stratum (< 9.0% or ≥ 9.0%), week, and treatment by week interaction as fixed factors, and baseline value as a covariate.
Danish: QD=én gang daglig, QW=én gang ugentlig, N=antal patienter, CI=konfidensinterval Justeret mindste kvadrat gennemsnit (LS gennemsnit) og behandlingsgruppedifference i ændringen fra basisværdierne i uge 28 modelleres ved hjælp af MMRM-metoden (Mixed Model Repeated Measures) inklusive behandling, region, baseline HbA1c-stratum (< 9,0% eller ≥ 9,0%), uge og behandling pr. uge interaktion som faste faktorer og baseline værdi som en kovariant.
English: - At blood ketone readings over 3.0 mmol/L (or urine ketones reading +++) you probably have diabetic ketoacidosis, go to the emergency department without delay and stop taking Forxiga.
Danish: - Ved blodketonmåling over 3,0 mmol/l (eller urinketonmåling +++) har du sandsynligvis diabetisk ketoacidose, tag straks på skadestuen og stop med at tage Forxiga.
English: • low blood sugar levels (hypoglycaemia) - when taking this medicine with a sulphonylurea or insulin These are the signs of low blood sugar: - shaking, sweating, feeling very anxious, fast heart beat - feeling hungry, headache, change in vision - a change in your mood or feeling confused.
Danish: • lavt blodsukker (hypoglykæmi) - når Forxiga tages sammen med et sulfonylurinstof eller insulin Følgende er tegn på lavt blodsukker: - rysten, svedtendens, stærk angstfølelse, hurtig hjerterytme (puls) - sultfornemmelse, hovedpine, synsforstyrrelser - humørsvingninger eller forvirring.
English: Diabetic ketoacidosis (when used in type 1 diabetes mellitus)
Danish: Diabetisk ketoacidose (når anvendt til type 1diabetes mellitus)
English: The proportion of subjects remaining in the study at Week 104 and Week 208 was 56.2% and 39.7% for the group treated with dapagliflozin and 50.0% and 34.6% for the group treated with glipizide.
Danish: Andelen af forsøgspersoner, der stadig indgik i studiet i uge 104 og uge 208 var 56,2 % og 39,7 % i dapagliflozingruppen og 50,0 % og 34,6 % i glipizid-gruppen.
English: Probable DKA > 3.0 mmol/L
Danish: > 3,0 mmol/l
English: Diabetic ketoacidosis (when used in type 2 diabetes mellitus)
Danish: Diabetisk ketoacidose (når anvendt til type 2diabetes mellitus)
English: Cardiovascular and renal outcomes
Danish: Kardiovaskulære og renale events
English: • If you experience feeling sick or being sick, stomach pain, excessive thirst, fast and deep breathing, confusion, unusual sleepiness or tiredness, a sweet smell to your breath, a sweet or metallic taste in your mouth, or a different odour to your urine or sweat or rapid weight loss.
Danish: • Hvis du oplever kvalme, opkastning, mavesmerter, udtalt tørst, hurtig og dyb vejrtrækning, forvirring, usædvanlig søvnighed eller træthed, dine ånde lugter sødligt, en sød eller metallisk smag i munden eller en forandret lugt af din urin eller sved eller hurtigt vægttab.
English: Type 2 diabetes: Medicinal product subject to medical prescription.
Danish: Type 2-diabetes : Lægemidlet er receptpligtigt
English: The European Medicines Agency has deferred the obligation to submit the results of studies with dapagliflozin in one or more subsets of the paediatric population in the treatment of type 2 diabetes mellitus and type 1 diabetes mellitus (see section 4.2 for information on paediatric use).
Danish: Det Europæiske Lægemiddelagentur har udsat kravet om at fremlægge resultaterne af studier med dapagliflozin i en eller flere undergrupper af den pædiatriske population til behandling af type 2diabetes mellitus og type 1-diabetes mellitus (se pkt.
English: Treatment with dapagliflozin 10 mg as an add-on to glimepiride resulted in statistically significant reductions in 2-hour post-prandial glucose at 24 weeks that were maintained up to Week 48.
Danish: Behandling med dapagliflozin 10 mg som tillægsbehandling til glimepirid resulterede i statistisk signifikante reduktioner i 2-timers postprandial glukose efter 24 uger, som blev opretholdt op til og med uge 48.
English: Subjects (%) achieving HbA1c 7%
Danish: Forsøgspersoner (%) som opnåede HbA1c < 7%
English: Other medicines and Forxiga Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
Danish: Fortæl det til lægen, apotekspersonalet eller sundhedspersonalet, hvis du bruger anden medicin, har gjort det for nylig eller påtænker at gøre det.
English: Combination therapy with prolonged-release exenatide In a 28-week, double-blind, active comparator-controlled study, the combination of dapagliflozin and prolonged-release exenatide (a GLP-1 receptor agonist) was compared to dapagliflozin alone and prolonged-release exenatide alone in subjects with inadequate glycaemic control on metformin alone (HbA1c ≥ 8% and ≤ 12%).
Danish: Kombinationsbehandling med depotformulering af exenatid I et 28-ugers dobbeltblindt, aktiv komparatorkontrolleret studie, blev kombinationen af dapagliflozin og depotformulering af exenatid (en GLP-1 receptoragonist) sammenlignet med dapagliflozin alene og depotformulering af exenatid alene hos personer med utilstrækkelig glykæmisk kontrol på metformin alene (HbA1c ≥ 8% og ≤ 12%).
English: Urine glucose Because of how Forxiga works, your urine will test positive for sugar while you are on this medicine.
Danish: På grund af Forxigas virkemåde vil urinprøver vise, at du har sukker (glukose) i urinen, mens du tager denne medicin.
English: What Forxiga looks like and contents of the pack Forxiga 10 mg film-coated tablets are yellow and diamond-shaped approximately 1.1 x 0.8 cm diagonally.
Danish: • Forxiga 10 mg filmovertrukne tabletter er gule og diamantformede og måler ca. 1,1 x 0,8 cm diagonalt.
English: Subjects (%) achieving ≥ 0.5% reductions in HbA1c without severe hypoglycaemia Body weight (kg) Baseline (mean) Change from baseline Difference from placebo 95% CI
Danish: Patienter (%) som opnåede ≥ 0,5 % reduktion i HbA1c uden alvorlig hypoglykæmi Kropsvægt (kg) Baseline (gennemsnitlig) Ændring fra baseline Forskel fra placebo 95% CI
English: 0.6-1.5 mmol/L Trace or Small
Danish: 0,6-1,5 mmol/l
English: Impending DKA > 1.5-3.0 mmol/L Moderate
Danish: > 1,5-3,0 mmol/l
English: These are the signs of diabetic ketoacidosis (see also section 2 Warnings and precautions): - increased levels of “ketone bodies” in your urine or blood - feeling sick or being sick - stomach pain - excessive thirst - fast and deep breathing - confusion - unusual sleepiness or tiredness - a sweet smell to your breath, a sweet or metallic taste in your mouth or a different odour to your urine or sweat - rapid weight loss.
Danish: Advarsler og forsigtighedsregler): - forhøjet niveau af ”ketonstoffer” i urinen eller blodet - kvalme eller opkastning - mavesmerter - udtalt tørst - hurtig og dyb vejrtrækning - forvirring - usædvanlig søvnighed eller træthed - dine ånde lugter sødligt, en sød eller metallisk smag i munden eller en forandret lugt af din urin eller sved - hurtigt vægttab.
English: Ketonaemia
Danish: Ketonuri
English: Fourteen double-blind, randomised, controlled clinical studies were conducted with 7,056 subjects with type 2 diabetes to evaluate the glycaemic efficacy and safety of Forxiga; 4,737 subjects in these studies were treated with dapagliflozin.
Danish: Der blev udført 14 dobbeltblinde, randomiserede, kontrollerede kliniske studier med 7.056 forsøgspersoner med type 2-diabetes for at vurdere Forxigas sikkerhed og glykæmiske virkning.
English: The combination treatment with dapagliflozin 10 mg and prolonged-release exenatide group showed superior reductions in HbA1c from baseline compared to dapagliflozin alone and prolonged-release exenatide alone (Table 9).
Danish: Gruppen med kombinationsbehandling med dapagliflozin 10 mg og depotformulering af exenatid, viste bedre reduktion af HbA1c fra baseline sammenlignet med dapagliflozin alene og depotformulering af exenatid alene (tabel 9).
English: Forxiga5mg tablets are available in aluminium blisters in pack sizes of 14, 28 or 98film-coated tablets in non-perforated calendar blisters and 30x1 or 90x1 film-coated tablets in perforated unit dose blisters.
Danish: Forxiga 5 mg tabletter fås som blisterkort af aluminium i pakninger med 14, 28 eller 98 filmovertrukne tabletter i ikke-perforerede kalender-blisterkort og 30x1 eller 90x1 filmovertrukne tabletter i perforerede enkeltdosis-blisterkort.
English: Forxiga10mg tablets are available in aluminium blisters in pack sizes of 14, 28 or 98film-coated tablets in non-perforated calendar blisters and 30x1 or 90x1 film-coated tablets in perforated unit dose blisters.
Danish: Forxiga 10 mg tabletter fås som blisterkort af aluminium i pakninger med 14, 28 eller 98 filmovertrukne tabletter i ikke-perforerede kalender-blisterkort og 30x1 eller 90x1 filmovertrukne tabletter i perforerede enkeltdosis-blisterkort.
English: (95% CI) Subjects (%) achieving: HbA1c < 7% Adjusted for baseline
Danish: Forsøgspersoner (%) der opnåede: HbA1c < 7 % Justeret for baseline
English: Forxiga should not be initiated in patients with a glomerular filtration rate [GFR] < 60 mL/min and should be discontinued at GFR persistently below 45 mL/min (see sections 4.4, 4.8, 5.1 and 5.2).
Danish: Forxiga bør ikke initieres hos patienter med en glomerulær filtrationshastighed [GFR] < 60 ml/min og skal seponeres ved en vedvarende GFR under 45 ml/min (se pkt.
English: Vulvovaginitis, balanitis and related genital infections includes, e.g. the predefined preferred terms: vulvovaginal mycotic infection, vaginal infection, balanitis, genital infection fungal, vulvovaginal candidiasis,
Danish: Vulvovaginitis, balanitis og relaterede genitale infektioner omfatter de foruddefinerede foretrukne termer: vulvovaginal mykotisk infektion, vaginal infektion, balanitis, genital svampeinfektion, vulvovaginal candidiasis, vulvovaginitis, balanitis candida, genital candidiasis, genital infektion, genital mandlig infektion, penisinfektion,
English: HbA1c (%) Baseline (mean) Change from baseline Difference from placebo 95% CI
Danish: HbA1c (%) Baseline (gennemsnitlig) Ændring fra baseline Forskel fra placebo 95% CI
English: • The other ingredients are: tablet core: microcrystalline cellulose (E460i), lactose (see section 2 ‘Forxiga contains lactose'), crospovidone (E1202), silicon dioxide (E551), magnesium stearate (E470b).
Danish: • Øvrige indholdsstoffer: tabletkerne: mikrokrystallinsk cellulose (E460i), laktose (se punkt 2.
English: LOCF: Last observation (prior to rescue for rescued subjects) carried forward All randomised subjects who took at least one dose of double-blind study medication during the short-term double-blind period Least squares mean adjusted for baseline value p-value < 0.0001 versus placebo Not evaluated for statistical significance as a result of the sequential testing procedure for secondary end points
Danish: 2sitagliptin 100 mg/dag LOCF: Last observation carried forward (før behandling med rescue-medicin) Alle randomiserede forsøgspersoner, som tog mindst én dosis af den dobbeltblinde studiemedicin i den dobbeltblinde periode i korttidsstudierne Gennemsnit beregnet efter mindste kvadraters metode justeret for baselineværdi p-værdi < 0,0001 versus placebo + oralt glukosesænkende lægemiddel p-værdi < 0,05 versus placebo + oralt glukosesænkende lægemiddel
English: Blood urea increased
Danish: Øget urinstof i blodet
English: Least squares mean adjusted for baseline value p-value < 0.0001 versus placebo + oral glucose-lowering medicinal product p-value < 0.05 versus placebo + oral glucose-lowering medicinal product
Danish: Gennemsnit beregnet efter mindste kvadraters metode justeret for baselineværdi p-værdi < 0,0001 versus placebo
English: Least squares mean adjusted for baseline value Non-inferior to glipizide + metformin p-value < 0.0001
Danish: Randomiserede og behandlede forsøgspersoner med baselineværdi og mindst 1 effektmåling efter baseline Gennemsnit beregnet efter mindste kvadraters metode justeret for baselineværdi Non-inferiority over for glipizid + metformin p-værdi < 0,0001
English: • low blood sugar levels (hypoglycaemia) - when taking this medicine with a sulphonylurea or insulin
Danish: Meget almindelige (kan forekomme hos op til 1 ud af 10 personer) • lavt blodsukker (hypoglykæmi) - når Forxiga tages sammen med et sulfonylurinstof eller insulin
English: Nocturia
Danish: Forxiga.
English: Driving and using machines Forxiga has no or negligible influence on the ability to drive and use machines.
Danish: svedudbrug eller synspåvirkning og kan påvirke din evne til at færdes i trafikken eller betjene maskiner.
English: (95% CI) Subjects (%) achieving: HbA1c < 7% Adjusted for baseline Body weight (kg) Baseline (mean) Change from baseline Difference from placebo c
Danish: HbA1c (%) Baseline (gennemsnitlig) Ændring fra baseline Forskel fra placebo (95 % CI) Forsøgspersoner (%), der opnår: HbA1c < 7 % Justeret for baseline Legemsvægt (kg) Baseline (gennemsnitlig) Ændring fra baseline Forskel fra placebo (95 % CI)
English: What Forxiga looks like and contents of the pack Forxiga 5 mg film-coated tablets are yellow and round with diameter of 0.7 cm.
Danish: Forxiga 5 mg filmovertrukne tabletter er gule og runde med en diameter på 0,7 cm. Der står "5" på den ene side og "1427" på den anden side.
English: Children and adolescents
Danish: Antydning eller lille
English: Baseline (mean) Change from baseline Difference from dapagliflozin c
Danish: Baseline (gennemsnitlig) Ændring fra baselinec Forskel fra placebo
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances:
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING Aktivstoffer:
English: ATCvet code: QP53AX73.
Danish: ATCvet-kode: QP53AX73.
English: All cats within the household should be treated.
Danish: Alle husstandens katte bør behandles.
English: It is therefore recommended to treat the animal in the evening.
Danish: Det anbefales derfor at behandle katte om aftenen.
English: Vectra Felis should not enter water courses as this may be dangerous for fish and other aquatic organisms.
Danish: Vectra Felis må ikke komme i kontakt med vandløb, da dette kan være farligt for fisk og andre vandorganismer.
English: The veterinary medicinal product is irritating to the eyes and skin.
Danish: Dette veterinærlægemiddel er irriterende for øjne og hud.
English: • Avoid contact with the skin, eyes or mouth.
Danish: • Undgå kontakt med hud, øjne og mund
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 06/06/2014
Danish: DATO FOR FØRSTE TILLADELSE/FORNYELSE AF TILLADELSEN Dato for første markedsføringstilladelse: 06 / 06 / 2014
English: The parasite comes in contact with the treated cat and is then killed.
Danish: Parasitten kommer i kontakt med den behandlede kat og bliver derved dræbt.
English: Do not administer orally or via any other route.
Danish: Skal ikke indgives oralt eller af nogen anden vej.
English: Dogs in the household should only be treated with a veterinary medicinal product authorised for use in that species.
Danish: Husstandens hunde bør kun behandles med et veterinærlægemiddel, der er godkendt til brug hos denne art.
English: EU/2/14/165/001 (1 spot-on applicator) EU/2/14/165/002 (3 spot-on applicators) EU/2/14/165/006 (4 spot-on applicators) EU/2/14/165/003 (6 spot-on applicators) EU/2/14/165/004 (12 spot-on applicators) EU/2/14/165/007 (24 spot-on applicators)
Danish: EU/2/14/165/001 (1 spot-on-applikator) EU/2/14/165/002 (3 spot-on-applikatorer) EU/2/14/165/006 (4 spot-on-applikatorer) EU/2/14/165/003 (6 spot-on-applikatorer) EU/2/14/165/004 (12 spot-on-applikatorer) EU/2/14/165/007 (24 spot-on-applikatorer)
English: Dimethyl sulfoxide
Danish: Dimetylsulfoxid
English: Fleas are killed by dinotefuran within 2 hours after treatment or infestation.
Danish: Lopper dræbes af dinotefuran inden for to timer efter behandling eller infestation.
English: Dinotefuran and pyriproxyfen are partially absorbed by the cat skin (30% and 12% respectively), but this systemic absorption is not relevant for the clinical efficacy of the product.
Danish: Dinotefuran og pyriproxyfen absorberes delvist i kattens hud (henholdsvis 30% og 12%), men den systemiske absorption er ikke relevant for produktets kliniske effekt.
English: The need to re-treat cats which are likely to be re-infested, and the time interval between such treatments, should be based on an assessment by a veterinarian.
Danish: Behovet for at genbehandle katte, som har en sandsynlighed for reinfestation, og intervallet mellem sådanne behandlinger, skal baseres på en dyrlæges vurdering.
English: The actives act directly on the cat's coat without any need to infiltrate the blood flow.
Danish: De aktive stoffer virker direkte på kattens pels uden behov for at trænge ind i blodbanen.
English: Spot-on use.
Danish: Spot-on-anvendelse.
English: Shelf life of the veterinary medicinal product as packaged for sale: 3 years.
Danish: Opbevaringstid for veterinærlægemidlet i salgspakning: tre år.
English: It acts through contact, by mimicking the juvenile hormone which regulates the moulting of insects from one life stage to the next.
Danish: Det virker via kontakt ved at efterligne det juvenile hormon, som regulerer insekternes hudskifte fra ét livsstadie til et andet.
English: Hyperactivity and tachypnoea may occur very rarely.
Danish: Hyperaktivitet og takypnø kan forekomme meget sjældent.
English: • Treated animals should not be allowed to sleep with their owners, especially children, on the day of treatment.
Danish: • På behandlingsdagen bør katte ikke have adgang til at sove sammen med deres ejere - især ikke sammen med børn.
English: This veterinary medicine kills fleas (Ctenocephalides felis) on infested cats and prevents further infestations for one month.
Danish: Dette veterinærlægemiddel dræber lopper (Ctenocephalides felis) på infesterede katte og forhindrer yderligere infestation i en måned.